INNOVATE Corp (VATE)

Form 8-K - Current report

Form 8-K - Current report

INNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of Broadcasting

NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

INNOVATE Corp. Announces First Quarter 2026 Results

- Infrastructure: Strong first quarter results with revenue of $357.9 million - Life Sciences: MediBeacon...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

INNOVATE Corp. to Report First Quarter 2026 Results on May 14th

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”...

Form 8-K - Current report

INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend

NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”...

DBM Global to Pay Cash Dividend

PHOENIX, April 03, 2026 (GLOBE NEWSWIRE) -- DBM Global Inc. (“DBMG”), a family of companies providing fully...

Form 8-K - Current report

MediBeacon® Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”...

Form 8-K - Current report